Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 118.03M | 115.25M | 167.50M | 154.10M | 178.02M |
Gross Profit | 4.45M | 2.33M | 26.40M | 17.64M | 33.15M |
EBITDA | -6.22M | -1.11M | -46.68M | 5.23M | 19.02M |
Net Income | -38.18M | -29.38M | -74.50M | -31.00M | -2.89M |
Balance Sheet | |||||
Total Assets | 247.05M | 273.51M | 296.10M | 351.22M | 371.29M |
Cash, Cash Equivalents and Short-Term Investments | 4.66M | 5.62M | 11.60M | 10.79M | 24.66M |
Total Debt | 73.99M | 54.15M | 77.60M | 70.98M | 69.76M |
Total Liabilities | 112.94M | 103.73M | 121.00M | 116.60M | 110.85M |
Stockholders Equity | 134.11M | 169.78M | 175.10M | 234.62M | 260.44M |
Cash Flow | |||||
Free Cash Flow | -17.72M | -12.20M | -12.00M | -3.00M | 22.92M |
Operating Cash Flow | -2.88M | 5.92M | 5.90M | 15.39M | 33.32M |
Investing Cash Flow | -10.19M | -17.96M | -10.70M | -18.30M | -11.77M |
Financing Cash Flow | 12.16M | 6.63M | 4.80M | -11.17M | -5.55M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
65 Neutral | £44.02M | 197.30 | 0.50% | 5.03% | -26.16% | -99.62% | |
61 Neutral | $35.48B | 7.63 | -10.11% | 1.88% | 8.73% | -9.23% | |
47 Neutral | £88.39M | ― | -25.13% | ― | 2.41% | -16.47% | |
― | $1.40B | 43.64 | 7.03% | 1.17% | ― | ― | |
57 Neutral | £134.22M | 24.65 | 4.79% | 2.67% | 1.74% | 359.50% | |
52 Neutral | £22.88M | ― | -5780.00% | ― | -8.06% | -132.47% | |
46 Neutral | £44.62M | 29.30 | -0.04% | 3.93% | 0.03% | -100.84% |
IQE plc has amended its ‘Total Voting Rights’ announcement, initially released on 1 August 2025. As of 31 July 2025, the company’s issued share capital consists of 976,688,331 ordinary shares, with 4,115 held in treasury, resulting in 976,684,216 shares with voting rights. Shareholders should use this figure for calculations related to the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:IQE) stock is a Buy with a £0.45 price target. To see the full list of analyst forecasts on IQE plc stock, see the GB:IQE Stock Forecast page.
IQE plc has announced its total voting rights as of 31 July 2025, with the company’s issued share capital consisting of 967,403,009 ordinary shares, of which 967,398,894 have voting rights. This figure is crucial for shareholders to determine the need to notify their interest or changes in interest under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules. This announcement provides clarity on shareholder voting rights, which is essential for maintaining transparency and compliance with regulatory requirements.
The most recent analyst rating on (GB:IQE) stock is a Buy with a £20.00 price target. To see the full list of analyst forecasts on IQE plc stock, see the GB:IQE Stock Forecast page.
IQE plc announced the issuance of nil cost share options to its Executive Chair, Mark Cubitt, and CEO, Jutta Meier, as part of the company’s Long Term Incentive Plan. This move reflects their increased responsibilities and workloads, with both executives opting to receive their pay adjustments as options, which will vest monthly but are not exercisable until 2026. This strategic decision aligns with IQE’s efforts to incentivize its leadership team and potentially enhance stakeholder value by tying compensation to the company’s long-term performance.
The most recent analyst rating on (GB:IQE) stock is a Buy with a £0.45 price target. To see the full list of analyst forecasts on IQE plc stock, see the GB:IQE Stock Forecast page.
IQE plc announced its total voting rights and block admission return as of 30 June 2025. The company’s issued share capital consists of 976,505,562 ordinary shares, with 976,501,447 shares having voting rights. This update is crucial for shareholders to determine their interest in the company under the Financial Conduct Authority’s rules. Additionally, during the period from 1 January 2025 to 30 June 2025, 9,254,445 ordinary shares were issued under the company’s all-employee share option plan, leaving a balance of 6,531,834 shares not yet issued. This update reflects the company’s ongoing commitment to its employee share scheme and provides transparency to its stakeholders.
The most recent analyst rating on (GB:IQE) stock is a Buy with a £0.45 price target. To see the full list of analyst forecasts on IQE plc stock, see the GB:IQE Stock Forecast page.
IQE plc announced the successful passing of all resolutions at its 2025 Annual General Meeting held in London. The resolutions included the receipt of the Directors’ Report and Financial Statements, approval of the Directors’ Annual Report on Remuneration, and the election and re-election of several board members. The reappointment of the auditor and the directors’ authority to allot shares were also approved. The meeting’s outcomes reinforce IQE’s operational stability and governance, potentially strengthening its market position and stakeholder confidence.
The most recent analyst rating on (GB:IQE) stock is a Buy with a £0.45 price target. To see the full list of analyst forecasts on IQE plc stock, see the GB:IQE Stock Forecast page.
IQE plc announced it will host its Annual General Meeting (AGM) today in London, with shareholders able to attend in person. The results of the AGM will be shared via the Regulatory News Service following the meeting, which is significant for stakeholders as it provides updates on the company’s strategic direction and operational performance.
The most recent analyst rating on (GB:IQE) stock is a Buy with a £20.00 price target. To see the full list of analyst forecasts on IQE plc stock, see the GB:IQE Stock Forecast page.
IQE plc and Quinas Technology have completed a £1.1 million project funded by Innovate UK to develop a scalable production method for ULTRARAM™, the world’s first quantum-powered universal memory. This project marks a significant step towards commercial production, with IQE achieving a world-first in scalable epitaxy for memory devices. ULTRARAM™ combines the non-volatility of flash memory with the speed and endurance of DRAM, offering improved energy efficiency. The project supports the UK Government’s semiconductor strategy, positioning the UK as a leader in next-generation memory innovation, with potential applications in AI, quantum computing, space, and defense.
The most recent analyst rating on (GB:IQE) stock is a Buy with a £0.45 price target. To see the full list of analyst forecasts on IQE plc stock, see the GB:IQE Stock Forecast page.
IQE plc has announced a change in its major holdings, with Canaccord Genuity Group Inc. reducing its voting rights in the company from 10.9929% to 9.9982%. This adjustment in holdings reflects a slight decrease in Canaccord’s influence over IQE’s corporate decisions, which could impact the company’s strategic direction and stakeholder interests.
The most recent analyst rating on (GB:IQE) stock is a Buy with a £0.45 price target. To see the full list of analyst forecasts on IQE plc stock, see the GB:IQE Stock Forecast page.
IQE plc announced the issuance of nil cost share options to its Executive Chair, Mark Cubitt, and CEO, Jutta Meier, under its Long Term Incentive Plan. Mark Cubitt received options over 166,667 ordinary shares, with plans for similar future grants, reflecting his increased time commitment and contributions during the strategic review. Jutta Meier was granted options over 5,666,667 ordinary shares, with vesting tied to financial and strategic performance targets. These grants aim to align the interests of key executives with shareholders, potentially impacting the company’s strategic direction and stakeholder confidence.
The most recent analyst rating on (GB:IQE) stock is a Buy with a £0.45 price target. To see the full list of analyst forecasts on IQE plc stock, see the GB:IQE Stock Forecast page.
IQE plc has announced the publication of its 2025 Notice of Annual General Meeting (AGM) and its 2024 Annual Report and Accounts, both available on the company’s website. The AGM is scheduled for June 30, 2025, in London, where shareholders can vote and pose questions to the Board. This announcement underscores IQE’s commitment to transparency and shareholder engagement, potentially impacting its market positioning and stakeholder relations.
The most recent analyst rating on (GB:IQE) stock is a Buy with a £0.45 price target. To see the full list of analyst forecasts on IQE plc stock, see the GB:IQE Stock Forecast page.
IQE plc announced its full-year 2024 financial results, showing improved profitability and a strategic shift in focus. The company reported a slight increase in revenue to £118.0m and a significant rise in adjusted EBITDA by 88% year-on-year, reflecting cost reduction efforts and operational optimizations. Despite challenges in the macroeconomic environment, IQE is progressing with a strategic review, including potential asset sales and an IPO, to strengthen its financial position. Jutta Meier has been appointed as the CEO, continuing her role as CFO, and will lead the company through its ongoing strategic initiatives.
The most recent analyst rating on (GB:IQE) stock is a Buy with a £0.45 price target. To see the full list of analyst forecasts on IQE plc stock, see the GB:IQE Stock Forecast page.